ZA955292B - Medical use of bromelain - Google Patents

Medical use of bromelain

Info

Publication number
ZA955292B
ZA955292B ZA955292A ZA955292A ZA955292B ZA 955292 B ZA955292 B ZA 955292B ZA 955292 A ZA955292 A ZA 955292A ZA 955292 A ZA955292 A ZA 955292A ZA 955292 B ZA955292 B ZA 955292B
Authority
ZA
South Africa
Prior art keywords
bromelain
medical use
medical
Prior art date
Application number
ZA955292A
Inventor
Tracey Leahanne Mynott
Christian Engwerda
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of ZA955292B publication Critical patent/ZA955292B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA955292A 1994-06-24 1995-06-26 Medical use of bromelain ZA955292B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9412711A GB9412711D0 (en) 1994-06-24 1994-06-24 Medical use of bromelain

Publications (1)

Publication Number Publication Date
ZA955292B true ZA955292B (en) 1997-07-28

Family

ID=10757263

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955292A ZA955292B (en) 1994-06-24 1995-06-26 Medical use of bromelain

Country Status (13)

Country Link
EP (1) EP0766565A1 (en)
JP (1) JPH10502073A (en)
KR (1) KR970703784A (en)
CN (1) CN1151119A (en)
AU (1) AU2749395A (en)
CA (1) CA2193654A1 (en)
FI (1) FI965204A (en)
GB (1) GB9412711D0 (en)
IL (1) IL114331A0 (en)
NO (1) NO965564L (en)
TW (1) TW403654B (en)
WO (1) WO1996000082A1 (en)
ZA (1) ZA955292B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526691D0 (en) * 1995-12-29 1996-02-28 Cortecs Ltd Medical use of proteases
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
WO1998038320A1 (en) 1997-02-25 1998-09-03 Cortecs (Uk) Limited Component of bromelain
EP1908823B1 (en) * 1997-02-25 2011-11-16 Sarantis Pty Ltd Component of bromelain
NO304766B1 (en) 1997-06-16 1999-02-08 Sintef fingerprint Sensor
DE19726244C2 (en) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Use of proteolytic enzymes and rutoside to prevent or treat graft rejection
DE19726255C2 (en) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Influence of cytokines by proteolytic enzymes and rutoside
DE19726254C2 (en) * 1997-06-20 1999-10-21 Mucos Pharma Gmbh & Co Tolerance induction through proteases
GB9713667D0 (en) * 1997-06-27 1997-09-03 Cortecs Ltd Enhancement of intestinal permeability
GB9819138D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
DE19847114A1 (en) * 1998-10-13 2000-04-20 Mucos Pharma Gmbh & Co Use of proteolytic enzymes to modulate hyperactive T cells, especially for symptomatic treatment of immune-mediated inflammatory diseases, e.g. multiple sclerosis, diabetes, arthritis or glomerulonephritis
WO2000035436A2 (en) * 1998-12-16 2000-06-22 Warner-Lambert Company Treatment of arthritis with mek inhibitors
DE19957318A1 (en) * 1999-11-29 2001-06-21 Mucos Pharma Gmbh & Co Influence of TGF-beta by proteolytic enzymes
DE10018980A1 (en) * 2000-04-17 2001-11-08 Mucos Pharma Gmbh & Co Prophylaxis and therapy of diabetes mellitus I using proteolytic enzymes
EP1208849B1 (en) * 2000-11-28 2015-10-28 URSAPHARM Arzneimittel GmbH Use of bromelain for adjuvant therapy during wound healing process
TW201419131A (en) 2012-11-09 2014-05-16 Health & Life Co Ltd Voice-assisted biomedical sensing apparatus
US9526768B2 (en) * 2014-11-13 2016-12-27 Jennifer Mai Compositions for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225122A (en) * 1983-05-23 1984-12-18 Kaken Pharmaceut Co Ltd Remedy and improver for cancerous cachexia
ATE119780T1 (en) * 1989-10-06 1995-04-15 Mucos Emulsions Gmbh CATABOLIC ENZYMES FOR INDUCTION OF TUMOR NECROSIS FACTOR (TNF).
DE4302060A1 (en) * 1993-01-26 1994-07-28 Mucos Pharma Gmbh & Co Use of bromelain as CD44 surface molecule modifier
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes

Also Published As

Publication number Publication date
CN1151119A (en) 1997-06-04
EP0766565A1 (en) 1997-04-09
FI965204A (en) 1997-02-21
WO1996000082A1 (en) 1996-01-04
AU2749395A (en) 1996-01-19
NO965564L (en) 1997-02-24
KR970703784A (en) 1997-08-09
NO965564D0 (en) 1996-12-23
GB9412711D0 (en) 1994-08-17
IL114331A0 (en) 1995-10-31
CA2193654A1 (en) 1996-01-04
TW403654B (en) 2000-09-01
JPH10502073A (en) 1998-02-24
FI965204A0 (en) 1996-12-23

Similar Documents

Publication Publication Date Title
IL114331A0 (en) Medical use of bromelain
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
GB9414157D0 (en) Medical use
GB9313188D0 (en) Medical use of enzymes
IL113992A0 (en) Use of copolymer-1
HUP9800146A3 (en) Thalidomide-derivatives and use of them
ZA951485B (en) Medical application of bromelain
HUP9901448A3 (en) Novel medical use
GB9526691D0 (en) Medical use of proteases
GB9412983D0 (en) Novel types of medical use for amphotericin b
ZA953237B (en) Medical treatment
EP0941105A4 (en) Pretraumatic use of hemoglobin
GB9313189D0 (en) Medical use of enzymes
GB9308164D0 (en) Medical use of enzymes
ZA934714B (en) Medical use of enzymes
ZA951440B (en) Novel opiold peptides for the treatment of pain and use thereof
GB9725478D0 (en) Treatment of cotton
GB9726745D0 (en) Treatment of medical conditions
GB9421398D0 (en) Medical treatment
GB9424728D0 (en) Medical treatment
ZA951421B (en) Medical treatment
GB9425164D0 (en) Medical treatment
GB9425773D0 (en) Medical treatment
PL319345A1 (en) Gene of human galactokinase